Predictions
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€49.15
01.06.22
01.06.22
-
01.06.23
01.06.23
-2.34%
11.06.22
11.06.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€29.55
31.05.22
31.05.22
€32.00
31.05.23
31.05.23
4.91%
04.06.22
04.06.22
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
flatexDEGIRO AG
Start price
Target price
Perf. (%)
€14.09
31.05.22
31.05.22
€10.00
31.05.23
31.05.23
-55.19%
08.12.22
08.12.22
EBIT growth > 30% per year expected
Known brand
Future proof or reliable business model
Higher EBIT margin than peer group
Rakuten Inc.
Start price
Target price
Perf. (%)
€5.43
30.05.22
30.05.22
-
30.05.26
30.05.26
-20.73%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Rakuten Inc.
Start price
Target price
Perf. (%)
€5.43
30.05.22
30.05.22
-
30.05.26
30.05.26
-20.73%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Rakuten Inc.
Start price
Target price
Perf. (%)
€5.43
30.05.22
30.05.22
-
30.05.26
30.05.26
-20.73%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Rakuten Inc.
Start price
Target price
Perf. (%)
€5.43
30.05.22
30.05.22
-
30.05.26
30.05.26
-20.73%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Rakuten Inc.
Start price
Target price
Perf. (%)
€5.43
30.05.22
30.05.22
-
30.05.26
30.05.26
-20.73%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Rakuten Inc.
Start price
Target price
Perf. (%)
€5.43
30.05.22
30.05.22
-
30.05.26
30.05.26
-20.73%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Deutsche Pfandbriefbank AG
Start price
Target price
Perf. (%)
€10.57
30.05.22
30.05.22
-
30.05.26
30.05.26
-58.35%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Heidelberger Druckmaschinen AG
Start price
Target price
Perf. (%)
€1.99
30.05.22
30.05.22
€3.10
30.06.22
30.06.22
-28.84%
01.07.22
01.07.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
flatexDEGIRO AG
Start price
Target price
Perf. (%)
€14.20
30.05.22
30.05.22
€18.00
30.05.23
30.05.23
-35.35%
30.05.23
30.05.23
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.19
30.05.22
30.05.22
-
30.05.23
30.05.23
-7.79%
11.06.22
11.06.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.29
29.05.22
29.05.22
-
29.05.23
29.05.23
-0.67%
09.06.22
09.06.22
Could be very worthwhile Investment >20% year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€3.28
29.05.22
29.05.22
-
29.05.23
29.05.23
-25.00%
12.06.22
12.06.22
Risky Investment
Compagnie Des Alpes
Start price
Target price
Perf. (%)
€16.04
28.05.22
28.05.22
-
28.05.23
28.05.23
-8.60%
29.05.23
29.05.23
Could be worthwhile Investment >10% per year
Concert Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.40
28.05.22
28.05.22
-
28.05.23
28.05.23
46.05%
24.04.23
24.04.23
Could be worthwhile Investment >10% per year
Novavax Inc.
Start price
Target price
Perf. (%)
€51.80
27.05.22
27.05.22
€68.00
27.05.23
27.05.23
-32.47%
27.08.22
27.08.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Novavax Inc.
Start price
Target price
Perf. (%)
€42.61
25.05.22
25.05.22
€40.00
25.05.23
25.05.23
21.57%
27.05.22
27.05.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€21.75
22.05.22
22.05.22
-
22.05.23
22.05.23
-78.27%
22.05.23
22.05.23
Chimerix Inc.
Start price
Target price
Perf. (%)
€2.00
19.05.22
19.05.22
-
19.05.23
19.05.23
-11.40%
24.05.22
24.05.22
Probably not worthwhile Investment
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€3.16
18.05.22
18.05.22
€15.00
18.05.23
18.05.23
292.41%
29.07.22
29.07.22
Could be worthwhile Investment >10% per year
Higher risks for its business
Risky balance sheet
American Public Ed.
Start price
Target price
Perf. (%)
€13.40
18.05.22
18.05.22
€18.00
18.05.23
18.05.23
-57.09%
19.05.23
19.05.23
Could be worthwhile Investment >10% per year
Good culture
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.08
18.05.22
18.05.22
-
18.05.23
18.05.23
-3.43%
16.10.22
16.10.22
Risky Investment